Tools

CVRX

CVRx, Inc. · NASDAQ

Performance

-14.01%

1W

+22.08%

1M

+10.8%

3M

+96.72%

6M

+23.05%

YTD

-37.94%

1Y

Profile

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Technical Analysis of CVRX 2025-01-31

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 56 indicating a neutral to slightly bullish outlook, while the Oscillators Score at 36 and the Technical Score at 42 suggest bearish tendencies. Overall, the combined scores imply a cautious market sentiment, leaning towards neutrality with some bearish pressure.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of CVRX

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.